Minute Insight: Boston Scientific Walks Away From MI Tech Deal, Citing Regulatory Hurdles

The Federal Trade Commission said it supports Boston Scientific’s decision to walk away from a planned $230m acquisition of Korea-based MI Tech. Boston Scientific said it could not obtain needed global regulatory approvals.

Minute Insight
• Source: Citeline/Alamy

More from Minute Insights

More from Medtech Insight